Viad (VVI) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viad in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" VVI shares.
View VVI analyst ratings or view top-rated stocks.

1 analysts have issued 1-year price targets for Viad's stock. Their VVI share price forecasts range from $42.00 to $45.00. On average, they predict the company's stock price to reach $43.50 in the next twelve months. This suggests a possible upside of 74.2% from the stock's current price.
View analysts price targets for VVI or view top-rated stocks among Wall Street analysts.

Viad's stock was trading at $24.39 at the beginning of the year. Since then, VVI stock has increased by 2.4% and is now trading at $24.97.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our VVI earnings forecast.

Viad Corp (NYSE:VVI) announced its quarterly earnings data on Thursday, November, 4th. The business services provider reported $0.58 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.75 by $1.17. The business services provider had revenue of $233.60 million for the quarter, compared to analysts' expectations of $150.27 million. Viad had a net margin of 2.76% and a trailing twelve-month return on equity of 20.26%. During the same period in the previous year, the business earned ($0.81) EPS.

ETFs with the largest weight of Viad (NYSE:VVI) stock in their portfolio include Invesco S&P SmallCap Industrials ETF (PSCI),

Viad issued an update on its second quarter 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $289.00 million-$313.00 million, compared to the consensus revenue estimate of $307.16 million.

5 employees have rated Viad Chief Executive Officer Steve W. Moster on Glassdoor.com. Steve W. Moster has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viad investors own include Pfizer (PFE), AbbVie (ABBV), Verizon Communications (VZ), Dynavax Technologies (DVAX), Enbridge (ENB), Procter & Gamble (PG), QUALCOMM (QCOM), Trevena (TRVN), Universal Technical Institute (UTI) and VBI Vaccines (VBIV).

Viad trades on the New York Stock Exchange (NYSE) under the ticker symbol "VVI."

Viad's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.53%), Victory Capital Management Inc. (8.33%), River Road Asset Management LLC (8.32%), Blue Grotto Capital LLC (6.70%), Allspring Global Investments Holdings LLC (6.44%) and Cannell Capital LLC (4.28%). Insiders that own company stock include Andrew B Benett, Ellen M Ingersoll, Jeffrey A Stelmach, Joshua Schechter and Steven W Moster.
View institutional ownership trends.

Shares of VVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VVI stock can currently be purchased for approximately $24.97.

Viad (NYSE:VVI) has a market capitalization of $520.13 million and generates $1.13 billion in revenue each year. The business services provider earns $23.22 million in net income (profit) each year or $0.55 on an earnings per share basis.

The company employs 3,387 workers across the globe.

Viad's mailing address is 1850 NORTH CENTRAL AVENUE SUITE 1900, PHOENIX AZ, 85004. The official website for the company is www.viad.com. The business services provider can be reached via phone at (602) 207-1000, via email at investorrelations@viad.com, or via fax at 602-207-5834.